Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Storage and handling A co-lyophilised blend is stored on the terms of its least stable component
While this property remains partially characterized, it explains reported benefits for conditions involving brain and spinal cord tissue
Stackable, Non-Suppressive Recovery Enhancement Unlike corticosteroids, NSAIDs, or AAS, BPC-157 does not: Suppress natural hormone production Interfere with training adaptations Alter blood pressure or cholesterol Require PCT or hormonal therapy This makes it ideal for: Year-round recovery support Injury prevention cycles Off-cycle tissue maintenance Bridging between high-stress training blocks Ideal BPC-157 Cycle Protocols Unlike suppressive or hepatotoxic compounds, BPC-157 can be cycled safely for longer periods , especially when the goal is complete tissue remodeling or recovery from chronic injury
Research-grade suppliers carry SLU-PP-332 in two main formats: 50 mg oral tablets (commonly sold as a 60-count bottle) and injectable vials at 5 mg or 10 mg strengths
Therapeutic Research Protocol Dose: 0.5 0.75 mg (variant 5 mg pen = 2030 clicks / variant 10 mg pen = 1015 clicks) Duration: 4 6 weeks Frequency: Daily Cycle Interval: 4 weeks off before next cycle Goal / Description: Used in muscle or tendon repair studies
